Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
NAS:OSUR's Cash-to-Debt is ranked higher than
95% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. NAS:OSUR: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:OSUR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.4  Med: 17.87 Max: No Debt
Current: No Debt
Equity-to-Asset 0.88
NAS:OSUR's Equity-to-Asset is ranked higher than
94% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. NAS:OSUR: 0.88 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:OSUR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.84 Max: 0.96
Current: 0.88
0.55
0.96
Interest Coverage No Debt
NAS:OSUR's Interest Coverage is ranked higher than
93% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 44.21 vs. NAS:OSUR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
NAS:OSUR' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 20.05
Beneish M-Score: -1.63
WACC vs ROIC
9.26%
42.97%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 24.68
NAS:OSUR's Operating Margin % is ranked higher than
92% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.72 vs. NAS:OSUR: 24.68 )
Ranked among companies with meaningful Operating Margin % only.
NAS:OSUR' s Operating Margin % Range Over the Past 10 Years
Min: -18.53  Med: -7.97 Max: 24.68
Current: 24.68
-18.53
24.68
Net Margin % 20.48
NAS:OSUR's Net Margin % is ranked higher than
91% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. NAS:OSUR: 20.48 )
Ranked among companies with meaningful Net Margin % only.
NAS:OSUR' s Net Margin % Range Over the Past 10 Years
Min: -43.98  Med: -7.4 Max: 20.48
Current: 20.48
-43.98
20.48
ROE % 14.68
NAS:OSUR's ROE % is ranked higher than
78% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.68 vs. NAS:OSUR: 14.68 )
Ranked among companies with meaningful ROE % only.
NAS:OSUR' s ROE % Range Over the Past 10 Years
Min: -25.18  Med: -5.07 Max: 14.68
Current: 14.68
-25.18
14.68
ROA % 13.01
NAS:OSUR's ROA % is ranked higher than
89% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.36 vs. NAS:OSUR: 13.01 )
Ranked among companies with meaningful ROA % only.
NAS:OSUR' s ROA % Range Over the Past 10 Years
Min: -20.9  Med: -4.38 Max: 13.01
Current: 13.01
-20.9
13.01
ROC (Joel Greenblatt) % 93.38
NAS:OSUR's ROC (Joel Greenblatt) % is ranked higher than
93% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.63 vs. NAS:OSUR: 93.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:OSUR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -47.87  Med: -22.92 Max: 93.38
Current: 93.38
-47.87
93.38
3-Year Revenue Growth Rate 8.40
NAS:OSUR's 3-Year Revenue Growth Rate is ranked higher than
65% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.90 vs. NAS:OSUR: 8.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:OSUR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.9 Max: 64.2
Current: 8.4
-15.7
64.2
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:OSUR's 30-Y Financials

Financials (Next Earnings Date: 2018-02-08)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

OSUR Guru Trades in Q4 2016

Paul Tudor Jones 87,661 sh (+64.49%)
Joel Greenblatt 51,091 sh (+34.16%)
Jim Simons 4,197,303 sh (+5.69%)
PRIMECAP Management 1,262,000 sh (-37.40%)
Ken Fisher 338,964 sh (-45.65%)
» More
Q1 2017

OSUR Guru Trades in Q1 2017

Chuck Royce 210,000 sh (New)
Mariko Gordon 98,620 sh (New)
Ken Fisher 503,594 sh (+48.57%)
Jim Simons 5,132,003 sh (+22.27%)
PRIMECAP Management 1,261,500 sh (-0.04%)
Joel Greenblatt 20,210 sh (-60.44%)
Paul Tudor Jones 18,800 sh (-78.55%)
» More
Q2 2017

OSUR Guru Trades in Q2 2017

Columbia Wanger 659,911 sh (New)
Mariko Gordon 2,821,506 sh (+2760.99%)
Ken Fisher 682,480 sh (+35.52%)
Chuck Royce 210,000 sh (unchged)
Paul Tudor Jones Sold Out
PRIMECAP Management 1,260,000 sh (-0.12%)
Jim Simons 5,103,903 sh (-0.55%)
Joel Greenblatt 15,908 sh (-21.29%)
» More
Q3 2017

OSUR Guru Trades in Q3 2017

Chuck Royce 210,338 sh (+0.16%)
PRIMECAP Management 1,259,000 sh (-0.08%)
Jim Simons 4,682,703 sh (-8.25%)
Mariko Gordon 2,570,660 sh (-8.89%)
Joel Greenblatt 13,555 sh (-14.79%)
Ken Fisher 556,455 sh (-18.47%)
Columbia Wanger 321,584 sh (-51.27%)
» More
» Details

Insider Trades

Latest Guru Trades with OSUR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2017-09-30 Reduce -8.89%0.26%$17.27 - $22.74 $ 18.19-9%2,570,660
Ken Fisher 2017-09-30 Reduce -18.47%$17.27 - $22.74 $ 18.19-9%556,455
Joel Greenblatt 2017-09-30 Reduce -14.79%$17.27 - $22.74 $ 18.19-9%13,555
Mariko Gordon 2017-06-30 Add 2760.99%2.8%$12.25 - $17.84 $ 18.1927%2,821,506
Ken Fisher 2017-06-30 Add 35.52%0.01%$12.25 - $17.84 $ 18.1927%682,480
Joel Greenblatt 2017-06-30 Reduce -21.29%$12.25 - $17.84 $ 18.1927%15,908
Ken Fisher 2017-03-31 Add 48.57%$8.48 - $12.93 $ 18.1976%503,594
Mariko Gordon 2017-03-31 New Buy0.07%$8.48 - $12.93 $ 18.1976%98,620
Joel Greenblatt 2017-03-31 Reduce -60.44%0.01%$8.48 - $12.93 $ 18.1976%20,210
Ken Fisher 2016-12-31 Reduce -45.65%$7.1 - $9.37 $ 18.19120%338,964
Joel Greenblatt 2016-12-31 Add 34.16%$7.1 - $9.37 $ 18.19120%51,091
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:SZSE:300595, NAS:LMNX, SZSE:300358, TSE:7730, TSE:7780, SZSE:300171, TSE:3593, NYSE:GKOS, LSE:AMS, XMCE:FAE, SZSE:300677, XKLS:7153, SHSE:603222, XKRX:048260, NAS:ATRI, SZSE:300061, NAS:LMAT, NAS:STAA, NAS:IRTC, SZSE:002432 » details
Traded in other countries:EP3.Germany,
Headquarter Location:USA
OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

Ratios

vs
industry
vs
history
PE Ratio 35.65
OSUR's PE Ratio is ranked lower than
73% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.08 vs. OSUR: 35.65 )
Ranked among companies with meaningful PE Ratio only.
OSUR' s PE Ratio Range Over the Past 10 Years
Min: 21.29  Med: 67.95 Max: 500.83
Current: 35.65
21.29
500.83
Forward PE Ratio 46.73
OSUR's Forward PE Ratio is ranked lower than
90% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.51 vs. OSUR: 46.73 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 35.65
OSUR's PE Ratio without NRI is ranked lower than
73% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. OSUR: 35.65 )
Ranked among companies with meaningful PE Ratio without NRI only.
OSUR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 21.29  Med: 67.63 Max: 500.83
Current: 35.65
21.29
500.83
Price-to-Owner-Earnings 60.66
OSUR's Price-to-Owner-Earnings is ranked lower than
85% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.51 vs. OSUR: 60.66 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
OSUR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.78  Med: 56.77 Max: 5235
Current: 60.66
12.78
5235
PB Ratio 4.34
OSUR's PB Ratio is ranked lower than
73% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. OSUR: 4.34 )
Ranked among companies with meaningful PB Ratio only.
OSUR' s PB Ratio Range Over the Past 10 Years
Min: 0.94  Med: 2.46 Max: 6.45
Current: 4.34
0.94
6.45
PS Ratio 7.27
OSUR's PS Ratio is ranked lower than
83% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.36 vs. OSUR: 7.27 )
Ranked among companies with meaningful PS Ratio only.
OSUR' s PS Ratio Range Over the Past 10 Years
Min: 1.53  Med: 3.82 Max: 9.03
Current: 7.27
1.53
9.03
Price-to-Free-Cash-Flow 46.63
OSUR's Price-to-Free-Cash-Flow is ranked lower than
81% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.99 vs. OSUR: 46.63 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
OSUR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.44  Med: 57.43 Max: 402.69
Current: 46.63
11.44
402.69
Price-to-Operating-Cash-Flow 39.35
OSUR's Price-to-Operating-Cash-Flow is ranked lower than
84% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.95 vs. OSUR: 39.35 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
OSUR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.73  Med: 34.6 Max: 2795
Current: 39.35
9.73
2795
EV-to-EBIT 25.37
OSUR's EV-to-EBIT is ranked lower than
68% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.17 vs. OSUR: 25.37 )
Ranked among companies with meaningful EV-to-EBIT only.
OSUR' s EV-to-EBIT Range Over the Past 10 Years
Min: -760.8  Med: -6.9 Max: 630
Current: 25.37
-760.8
630
EV-to-EBITDA 21.83
OSUR's EV-to-EBITDA is ranked lower than
77% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.83 vs. OSUR: 21.83 )
Ranked among companies with meaningful EV-to-EBITDA only.
OSUR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1517.9  Med: -5.9 Max: 327.5
Current: 21.83
-1517.9
327.5
EV-to-Revenue 6.29
OSUR's EV-to-Revenue is ranked lower than
81% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. OSUR: 6.29 )
Ranked among companies with meaningful EV-to-Revenue only.
OSUR' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5  Med: 2.9 Max: 8.3
Current: 6.29
0.5
8.3
Current Ratio 7.86
OSUR's Current Ratio is ranked higher than
92% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. OSUR: 7.86 )
Ranked among companies with meaningful Current Ratio only.
OSUR' s Current Ratio Range Over the Past 10 Years
Min: 2.34  Med: 7.22 Max: 20
Current: 7.86
2.34
20
Quick Ratio 7.23
OSUR's Quick Ratio is ranked higher than
93% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. OSUR: 7.23 )
Ranked among companies with meaningful Quick Ratio only.
OSUR' s Quick Ratio Range Over the Past 10 Years
Min: 1.87  Med: 6.45 Max: 18
Current: 7.23
1.87
18
Days Inventory 88.38
OSUR's Days Inventory is ranked higher than
68% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.23 vs. OSUR: 88.38 )
Ranked among companies with meaningful Days Inventory only.
OSUR' s Days Inventory Range Over the Past 10 Years
Min: 84.17  Med: 116.55 Max: 134.26
Current: 88.38
84.17
134.26
Days Sales Outstanding 68.13
OSUR's Days Sales Outstanding is ranked lower than
64% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.37 vs. OSUR: 68.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
OSUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.8  Med: 59.07 Max: 76.49
Current: 68.13
47.8
76.49
Days Payable 62.56
OSUR's Days Payable is ranked higher than
66% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.31 vs. OSUR: 62.56 )
Ranked among companies with meaningful Days Payable only.
OSUR' s Days Payable Range Over the Past 10 Years
Min: 38.26  Med: 45.41 Max: 65.49
Current: 62.56
38.26
65.49

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.20
OSUR's 3-Year Average Share Buyback Ratio is ranked higher than
80% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.10 vs. OSUR: -0.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OSUR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40.2  Med: -6.3 Max: 11
Current: -0.2
-40.2
11

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 8.50
OSUR's Price-to-Net-Cash is ranked higher than
69% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.35 vs. OSUR: 8.50 )
Ranked among companies with meaningful Price-to-Net-Cash only.
OSUR' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.89  Med: 7.9 Max: 173.78
Current: 8.5
1.89
173.78
Price-to-Net-Current-Asset-Value 6.12
OSUR's Price-to-Net-Current-Asset-Value is ranked higher than
52% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.73 vs. OSUR: 6.12 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
OSUR' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.4  Med: 8.33 Max: 56.48
Current: 6.12
1.4
56.48
Price-to-Tangible-Book 4.90
OSUR's Price-to-Tangible-Book is ranked lower than
63% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.82 vs. OSUR: 4.90 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
OSUR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.11  Med: 6.61 Max: 29.57
Current: 4.9
1.11
29.57
Price-to-Intrinsic-Value-Projected-FCF 3.70
OSUR's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
83% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. OSUR: 3.70 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
OSUR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.14  Med: 3.46 Max: 21.2
Current: 3.7
1.14
21.2
Price-to-Median-PS-Value 1.89
OSUR's Price-to-Median-PS-Value is ranked lower than
92% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. OSUR: 1.89 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
OSUR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.43  Med: 1.88 Max: 23.06
Current: 1.89
0.43
23.06
Price-to-Graham-Number 2.79
OSUR's Price-to-Graham-Number is ranked lower than
64% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. OSUR: 2.79 )
Ranked among companies with meaningful Price-to-Graham-Number only.
OSUR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.4  Med: 3.9 Max: 20.7
Current: 2.79
1.4
20.7
Earnings Yield (Greenblatt) % 3.92
OSUR's Earnings Yield (Greenblatt) % is ranked higher than
58% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. OSUR: 3.92 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
OSUR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -35  Med: -1.3 Max: 6.7
Current: 3.92
-35
6.7
Forward Rate of Return (Yacktman) % 48.47
OSUR's Forward Rate of Return (Yacktman) % is ranked higher than
97% of the 97 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.48 vs. OSUR: 48.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
OSUR' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -84.8  Med: 0.1 Max: 60.4
Current: 48.47
-84.8
60.4

More Statistics

Revenue (TTM) (Mil) $150.54
EPS (TTM) $ 0.51
Beta1.14
Short Percentage of Float3.69%
52-Week Range $8.21 - 23.01
Shares Outstanding (Mil)60.65

Analyst Estimate

Dec17 Dec18 Dec19 Dec20
Revenue (Mil $) 159 176 200 225
EPS ($) 0.43 0.39 0.51 0.64
EPS without NRI ($) 0.43 0.39 0.51 0.64
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}